DG02917 | |
DG番号 | DG02917 |
分類 | DGroup |
名称 | MAO substrate Monoamine oxidase substrate TYPE Metabolism |
ステム | - |
構造式 | |
メンバー | DG03178 MAOA substrate DG00836 Sumatriptan D00451 Sumatriptan (JAN/USP/INN) D00676 Sumatriptan succinate (JAN/USP) D00415 Zolmitriptan (JAN/USP/INN) DG00839 Almotriptan D02824 Almotriptan (USAN) D02825 Almotriptan malate (USP) DG01260 Safinamide D10158 Safinamide (USAN/INN) D10191 Safinamide mesylate (USAN); Safinamide mesilate (JAN) DG03179 MAOB substrate DG00213 Dopamine D07870 Dopamine (INN) D00633 Dopamine hydrochloride (JP18/USP) DG00013 Epinephrine D00095 Epinephrine (USP/INN); Adrenaline (JP18) D00996 Epinephrine hydrochloride (JAN) D02149 Epinephrine bitartrate (JAN/USP) DG00212 Norepinephrine D00076 Noradrenaline (JP18); Norepinephrine (INN) D05206 Norepinephrine bitartrate (USP) D08284 Norepinephrine hydrochoride D09794 Norepinephrine hydrochloride (JAN) DG00947 Escitalopram D07913 Escitalopram (INN) D02567 Escitalopram oxalate (JAN/USP) |
上位グループ | Metabolizing enzyme substrate |
注釈1 | - |
注釈2 | - |